Kedrion alongside IPOPI at the IPIC Congress in Madrid
The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus
Kedrion keeps Hemophilia therapy debate flowing in Latin America
A recent CLAHT Congress symposium restates current and future role of replacement therapy
Kedrion reaffirms its commitment for the global eradication of Rh disease
A worldwide initiative for maternal and fetal health launches in Florence, Italy
Leading medical-scientific event on Hemophilia held in Trieste, Italy
Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight
Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy
A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN
June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia
Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion
16th International Hemophilia Congress in Turkey
A scientific symposium on the prevention and eradication of inhibitors in patients affected by Hemophilia A
Kedrion renews its commitment to PID patients at ESID 2018
18th edition of the Biennial Meeting of the European Society for Immunodeficiencies helds in Lisbon (Oct. 24 to 27)
50 years of Anti-D celebrated at World Congress of Gynecology and Obstetrics in Rio De Janeiro
Kedrion supports educational symposium to help Rh disease awareness and eradication
EIGHT, the global educational initiative on Hemophilia A and its treatment
Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October